Cefotaxime in transurethral prostatectomy.

A total of 6 gm of cefotaxime was administered in six doses over four days to each of 83 patients undergoing transurethral prostatectomy. The first dose was given before (44 patients) or after (39 patients) surgery. There were no important postoperative differences between patients in the two groups. Urinary tract infections had been diagnosed in 17 patients before surgery and were found in three after surgery. There were no serious infectious complications in any patient.